FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Torsten Kessler

Research Profile

Procedures

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Christian Schwöppe; Jörg Stypmann; Caroline Zerbst; Alena Dreiling; Max Fröhlich; Carsten Höltke; Richard Holtmeier; Torsten Kessler; Simone Koenig; Rüdiger Liersch; Martin Lücke; Rolf M Mesters; Carsten Müller-Tidow; Laura Overkamp; Christoph Schliemann; Wolfgang E Berdel
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.
Peter Razlaf; Holger Reinecke; Matthias Stelljes; Johannes Waltenberger; Rainer Wiewrodt; Wolfgang E Berdel; Torsten Kessler; Michael Mohr; Dirk Pabst; Pia Lebiedz
Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis.
M Mohr; Carsten Müller-Tidow; Gerald Pühse; Michael Semik; Tilmann Spieker; K Wiebe; C Hamisch; I Hartig; Lothar Hertle; Torsten Kessler; Sabine Kliesch; U Krug; Rüdiger Liersch; Rolf M Mesters; Wolfgang E Berdel
High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Torsten Kessler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christian Schwöppe; Jörg Stypmann; Caroline Zerbst; Alena Dreiling; Max Fröhlich; Carsten Höltke; Richard Holtmeier; Torsten Kessler; Simone Koenig; Rüdiger Liersch; Martin Lücke; Rolf M Mesters; Carsten Müller-Tidow; Laura Overkamp; Christoph Schliemann; Wolfgang E Berdel
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.
Journal of medicinal chemistry 2013;56(6):2337-47.
2012: Peter Razlaf; Holger Reinecke; Matthias Stelljes; Johannes Waltenberger; Rainer Wiewrodt; Wolfgang E Berdel; Torsten Kessler; Michael Mohr; Dirk Pabst; Pia Lebiedz
Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis.
Respiratory medicine 2012;106(11):1509-16.
2012: M Mohr; Carsten Müller-Tidow; Gerald Pühse; Michael Semik; Tilmann Spieker; K Wiebe; C Hamisch; I Hartig; Lothar Hertle; Torsten Kessler; Sabine Kliesch; U Krug; Rüdiger Liersch; Rolf M Mesters; Wolfgang E Berdel
High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.
Bone marrow transplantation 2012;47(10):1321-5.
2012: Rüdiger Liersch; Bob Löwenberg; Carsten Müller-Tidow; Christoph Schliemann; Christian Schwöppe; Iris Appelmann; Michael Bayer; Wolfgang E Berdel; Christoph Biermann; Thomas Büchner; Joachim Gerss; Wolfgang Hiddemann; Torsten Kessler; Rolf M Mesters
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.
Blood 2012;119(22):5215-20.
2012: Ruth von Scheven; Wolfgang E Berdel; Pia Lebiedz; Tilmann Spieker; Andreas Uekoetter; Torsten Kessler
Fulminant invasive pulmonary mucormycosis with Rhizopus oryzae in a patient with severe aplastic anaemia and common variable immunodeficiency.
Mycoses 2012;55(2):e32-5.
2011: Michele Pohlen; Iris Appelmann; Hans U Gerth; Torsten Kessler; Steffen Koschmieder; Rüdiger Liersch; Rolf M Mesters; Carsten Müller-Tidow; Wolfgang E Berdel
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.
American journal of hematology 2011;86(12):E61-4.
2010: Johannes Dreischalück; Christian Schwöppe; Tilmann Spieker; Torsten Kessler; Klaus Tiemann; Ruediger Liersch; Christoph Schliemann; Michael Kreuter; Astrid Kolkmeyer; Heike Hintelmann; Rolf M Mesters; Wolfgang E Berdel
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile.
International journal of oncology 2010;37(6):1389-97.
2010: Cord Rehmsmeier; Torsten Kessler; Steffen Koschmieder; Matthias Ross; Matthias Weckesser; Johannes Wessling; Gabriele Koehler; Wolfgang E Berdel
Mixed response in interim positron emission tomography/computed tomography leads to detection of a gastrointestinal stromal tumor in a patient with mediastinal diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):e215-7.
2010: Christian Schwöppe; Torsten Kessler; Thorsten Persigehl; Ruediger Liersch; Heike Hintelmann; Johannes Dreischalück; Janine Ring; Christoph Bremer; Walter Heindel; Rolf M Mesters; Wolfgang E Berdel
Tissue-factor fusion proteins induce occlusion of tumor vessels.
Thrombosis research 2010;125 Suppl 2():S143-50.
2010: Robert M Radke; Torsten Kessler; Pia Lebiedz
Management of acute-onset and life-threatening respiratory distress of unusual aetiology.
BMJ case reports 2010;2010():.
2010: Torsten Kessler; Michael Bayer; Christian Schwöppe; Rüdiger Liersch; Rolf M Mesters; Wolfgang E Berdel
Compounds in clinical Phase III and beyond.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2010;180():137-63.
2010: Iris Appelmann; Rüdiger Liersch; Torsten Kessler; Rolf M Mesters; Wolfgang E Berdel
Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2010;180():51-81.
2009: Ralf Bieker; Torsten Kessler; Christian Schwöppe; Teresa Padró; Thorsten Persigehl; Christoph Bremer; Johannes Dreischalück; Astrid Kolkmeyer; Walter Heindel; Rolf M Mesters; Wolfgang E Berdel
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Blood 2009;113(20):5019-27.
2009: Niels Reinmuth; Ruediger Liersch; Miriam Raedel; Frauke Fehrmann; Nicole Fehrmann; Michael Bayer; Christian Schwoeppe; Torsten Kessler; Wolfgang Berdel; Michael Thomas; Rolf M Mesters
Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2009;124(7):1535-44.
2008: Torsten Kessler; Christian Schwöppe; Ruediger Liersch; Christoph Schliemann; Heike Hintelmann; Ralf Bieker; Wolfgang E Berdel; Rolf M Mesters
Generation of fusion proteins for selective occlusion of tumor vessels.
Current drug discovery technologies 2008;5(1):1-8.
2008: Torsten Kessler; M Mohr; Carsten Müller-Tidow; U Krug; U Brunnberg; B Mohr; Christoph Schliemann; Cristina Sauerland; Hubert Serve; Thomas Büchner; Wolfgang E Berdel; Rolf M Mesters
Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.
Leukemia research 2008;32(3):491-4.
2007: Thorsten Persigehl; Lars Matuszewski; Torsten Kessler; Alexander Wall; Norbert Meier; Wolfgang Ebert; Wolfgang E Berdel; Walter Heindel; Rolf M Mesters; Christoph Bremer
Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
Investigative radiology 2007;42(12):791-6.
2007: Niels Reinmuth; Sonja Rensinghoff; Miriam Raedel; Nicole Fehrmann; Christian Schwöppe; Torsten Kessler; Guido Bisping; Frank Hilberg; Gerald J Roth; Wolfgang E Berdel; Michael Thomas; Rolf M Mesters
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells.
International journal of oncology 2007;31(3):621-6.
2007: Christoph Schliemann; Ralf Bieker; Nils Thoennissen; Joachim Gerss; Rüdiger Liersch; Torsten Kessler; Thomas Büchner; Wolfgang E Berdel; Rolf M Mesters
Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia.
Leukemia 2007;21(9):1901-6.
2007: Thorsten Persigehl; Ralf Bieker; Lars Matuszewski; Alexander Wall; Torsten Kessler; Hendrik Kooijman; Norbert Meier; Wolfgang Ebert; Wolfgang E Berdel; Walter Heindel; Rolf M Mesters; Christoph Bremer
Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Radiology 2007;244(2):449-56.
2007: Torsten Kessler; Frauke Fehrmann; Ralf Bieker; Wolfgang E Berdel; Rolf M Mesters
Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies.
Current drug targets 2007;8(2):257-68.
2006: Christoph Schliemann; Ralf Bieker; Teresa Padro; Torsten Kessler; Heike Hintelmann; Thomas Buchner; Wolfgang E Berdel; Rolf M Mesters
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Haematologica 2006;91(9):1203-11.
2006: Michael Kreuter; Michael Paulussen; Johannes Boeckeler; Joachim Gerss; Horst Buerger; Caren Liebscher; Torsten Kessler; Heribert Jurgens; Wolfgang E Berdel; Rolf M Mesters
Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1904-11.
2005: Torsten Kessler; Ralf Bieker; Teresa Padró; Christian Schwöppe; Thorsten Persigehl; Christoph Bremer; Michael Kreuter; Wolfgang E Berdel; Rolf M Mesters
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6317-24.
2003: Ralf Bieker; Teresa Padró; Julia Kramer; Martin B Steins; Torsten Kessler; Stephan Retzlaff; Federico Herrera; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
Cancer research 2003;63(21):7241-6.
2003: Ralf Bieker; Torsten Kessler; Wolfgang E Berdel; Rolf M Mesters
Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Oncology reports 2003;10(6):1915-7.
2003: Martin B Steins; Ralf Bieker; Teresa Padró; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Thalidomide for the treatment of acute myeloid leukemia.
Leukemia & lymphoma 2003;44(9):1489-93.
2002: Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin B Steins; Stephan Retzlaff; H Bürger; Thomas Büchner; Torsten Kessler; F Herrera; Joachim Kienast; Carsten Müller-Tidow; Hubert Serve; Wolfgang E Berdel; Rolf M Mesters
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Leukemia 2002;16(7):1302-10.
2002: Martin B Steins; Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin Kropff; Joachim Kienast; Torsten Kessler; Thomas Buechner; Wolfgang E Berdel; Rolf M Mesters
Efficacy and safety of thalidomide in patients with acute myeloid leukemia.
Blood 2002;99(3):834-9.
2002: Torsten Kessler; A Pfeifer; Steven A. Silletti; Rolf M Mesters; Wolfgang E Berdel; Inder M Verma; David A Cheresh
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.
Annals of hematology 2002;81 Suppl 2():S69-70.
2001: Rolf M Mesters; Teresa Padró; Martin B Steins; Ralf Bieker; Stephan Retzlaff; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel
[Angiogenesis in patients with hematologic malignancies].
Onkologie 2001;24 Suppl 5():75-80.
2001: Dale L Boger; Joel Goldberg; Steven A. Silletti; Torsten Kessler; David A Cheresh
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3).
Journal of the American Chemical Society 2001;123(7):1280-8.
2001: Steven A. Silletti; Torsten Kessler; Joel Goldberg; Dale L Boger; David A Cheresh
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(1):119-24.
2000: A Pfeifer; Torsten Kessler; Steven A. Silletti; David A Cheresh; Inder M Verma
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12227-32.
1998: Andrea Schumacher; Torsten Kessler; Thomas Büchner; Dieter Wewers; Jürgen van de Loo
Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy -- a longitudinal study.
Leukemia 1998;12(4):586-92.